Literature DB >> 12356802

Ciprofloxacin resistance in Campylobacter jejuni: case-case analysis as a tool for elucidating risks at home and abroad.

.   

Abstract

OBJECTIVE: To determine factors independently associated with the acquisition of a ciprofloxacin-resistant Campylobacter jejuni infection.
METHODS: Self-completion questionnaires were used to collect clinical, demographic and exposure data from cases of campylobacter infection reported to a sentinel surveillance scheme in England and Wales. Isolates from those cases were referred to the Public Health Laboratory Service Campylobacter Reference Unit for speciation, subtyping and antimicrobial resistance testing. Cases infected with a ciprofloxacin-resistant C. jejuni were compared with cases infected with a sensitive strain using case-case analysis. Single risk variable analysis and logistic regression analysis were employed. The analysis was restricted by travel status to control for the confounding effect of foreign travel. RESULTS AND
CONCLUSION: Over half (55%) of the campylobacter infections acquired abroad were resistant to ciprofloxacin, compared with 10% of UK-acquired strains [relative risk 5.23; 95% confidence interval (CI) 4.58-5.96]. For travel-associated cases, ciprofloxacin-resistant infections were independently associated with travel to Spain [odds ratio (OR) 6.87; 95% CI 3.52-13.38], Portugal (OR 22.40; 95% CI 4.36-114.99) or Cyprus (OR 11.74; 95% CI 1.28-108.02), and the consumption of chicken (OR 4.95; 95% CI 2.12-11.56) or bottled water (OR 3.70; 95% CI 1.69-8.10). Indigenous cases infected with a ciprofloxacin-resistant strain were more likely to report the consumption of pre-cooked cold meats (OR 2.13; 95% CI 1.44-3.13). The risk of acquiring a ciprofloxacin-resistant campylobacter infection was strongly associated with foreign travel. Restricting the analyses by travel status revealed different sets of risk exposures for acquiring a resistant C. jejuni strain, suggesting that different intervention strategies will be required.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12356802     DOI: 10.1093/jac/dkf173

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  8 in total

1.  Risk factors for ciprofloxacin resistance in reported Campylobacter infections in southern Alberta.

Authors:  J Y M Johnson; L M McMullen; P Hasselback; M Louie; G Jhangri; L D Saunders
Journal:  Epidemiol Infect       Date:  2007-08-03       Impact factor: 2.451

2.  Prevalence and subtypes of ciprofloxacin-resistant Campylobacter spp. in commercial poultry flocks before, during, and after treatment with fluoroquinolones.

Authors:  Tom J Humphrey; Frieda Jørgensen; Jennifer A Frost; Haddy Wadda; Gil Domingue; Nicola C Elviss; Deborah J Griggs; Laura J V Piddock
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

3.  A multi-centre prospective case-control study of campylobacter infection in persons aged 5 years and older in Australia.

Authors:  R J Stafford; P Schluter; M Kirk; A Wilson; L Unicomb; R Ashbolt; J Gregory
Journal:  Epidemiol Infect       Date:  2006-11-30       Impact factor: 2.451

4.  Burden of illness and factors associated with duration of illness in clinical campylobacteriosis.

Authors:  A E Deckert; R J Reid-Smith; S Tamblyn; L Morrell; P Seliske; F B Jamieson; R Irwin; C E Dewey; P Boerlin; S A McEwen
Journal:  Epidemiol Infect       Date:  2013-03-08       Impact factor: 4.434

Review 5.  Travel-Related Antimicrobial Resistance: A Systematic Review.

Authors:  Hamid Bokhary; Krisna N A Pangesti; Harunor Rashid; Moataz Abd El Ghany; Grant A Hill-Cawthorne
Journal:  Trop Med Infect Dis       Date:  2021-01-16

6.  Prevalence, haemolytic and haemagglutination activities and antibiotic susceptibility profiles of Campylobacter spp. isolated from human diarrhoeal stools in Vhembe District, South Africa.

Authors:  A Samie; J Ramalivhana; E O Igumbor; C L Obi
Journal:  J Health Popul Nutr       Date:  2007-12       Impact factor: 2.000

7.  Quinolone-resistant Campylobacter infections: risk factors and clinical consequences.

Authors:  Jørgen Engberg; Jakob Neimann; Eva Møller Nielsen; Frank Møller Aerestrup; Vivian Fussing
Journal:  Emerg Infect Dis       Date:  2004-06       Impact factor: 6.883

8.  Non food-related risk factors of campylobacteriosis in Canada: a matched case-control study.

Authors:  André Ravel; Katarina Pintar; Andrea Nesbitt; Frank Pollari
Journal:  BMC Public Health       Date:  2016-09-27       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.